Randomized, placebo-controlled, multi-center study to assess the efficacy and safety of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligible to initiate antiviral therapy

  • Koch, Alvaro (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/086/30/11